"These trial results were extremely impressive and showed a level of response not seen before in clinical trials related to dementia."The post Clinical Trial: THC/CBD Formulation Reduces Alzheimer’s-Induced Agitation appeared first on NORML.
"As cannabis becomes legal and commercialized, the likelihood of using it over antidepressants seems to increase, especially among females," researchers concluded.The post Analysis: Women More Likely To Substitute Cannabis for Antidepressants Following Legalization appeared first on NORML.
According to the new memo, any use of marijuana remains "punishable under the Uniform Code of Military Justice."The post Federal: Memo Stipulates That Cannabis Remains Off-Limits to Military Personnel, Even if Rescheduled appeared first on NORML.
"This study of patients qualified for chronic or intractable pain found almost 55 percent of patients were able to improve their life enjoyment and pain interference within four months of starting medical cannabis."The post Study: Chronic Pain Patients Experience Improvements Following Enrollment in State-Authorized Medical Cannabis Program appeared first on NORML.
"The present findings align with previous research demonstrating the potential benefits of cannabis-based medicinal products in ASD," the study's authors concluded.The post Study: Cannabis Products Associated With Sustained Improvements in Patients With Autism Spectrum Disorder appeared first on NORML.
"These data offer a new line of investigation in RLS treatment, which can have a major clinical impact in this population."The post Study: Oral Cannabis Spray Mitigates Symptoms in Patients With Restless Legs Syndrome appeared first on NORML.
Weighted for their populations, in 2025 Black people were 6.4 times more likely as white people to be arrested for marijuana crimes in California.The post California: Black, Latino Residents Disproportionately Arrested for Cannabis Violations appeared first on NORML.
According to the Secretary of State's office, initiative proponents failed "to submit the required number of valid petition signatures, both in total number of signatures and required legislative districts."The post Idaho: Medical Cannabis Legalization Campaign Fails To Qualify for 2026 Ballot appeared first on NORML.
Forty-two percent of respondents said that they substituted cannabis for prescription anxiolytics or antidepressants.The post Survey: Women Frequently Substitute Cannabis for Prescription Drugs to Manage Anxiety, Depression appeared first on NORML.
The most significant reductions occurred in participants who consumed higher doses of CBD (up to 600 mg/day).The post Review: CBD Dosing Reduces Blood Pressure in a Dose-Dependent Manner appeared first on NORML.
"In this systematic review, cannabinoid-based therapies showed lower neuropsychiatric symptom and agitation scores than placebo in patients with moderate-to-severe AD."The post Cannabis-Based Therapies Improve Alzheimer’s-Related Agitation appeared first on NORML.
Of the 937 products evaluated, only 31 percent contained percentages of CBD that were within ±10 percent of what was advertised on the products' labels.The post Analysis: Many Hemp-Derived CBD Products Lack Accurate Labeling appeared first on NORML.
Over 95 percent of the study's participants ceased their use of opioids by the conclusion of the study.The post Study: Cannabis Inhalation Associated With Long-Term Pain Relief, Opioid-Sparing Effects in Patients With Treatment-Resistant Lower Back Pain appeared first on NORML.
Investigators identified "meaningful benefits" in patients' sleep quality, pain, and nocturnal urinary frequency following cannabis treatment.The post Study: Cannabis Treatment Provides “Meaningful Benefits” for Patients With Parkinson’s appeared first on NORML.
Taxes derived from the licensed sale of state-regulated adult-use cannabis products totaled more than $4.5 billion in 2025 – the highest amount ever recorded in a single year.The post Report: Adult-Use Cannabis Markets Have Generated Over $28 Billion in State Tax Revenue appeared first on NORML.
State-licensed retailers will begin selling cannabis products to those age 21 or older on July 1, 2027.The post Virginia: Provisions Regulating Adult-Use Cannabis Sales Codified into Law appeared first on NORML.
"Our findings fit within the broader literature showing that improved access to symptom-relieving treatments can affect labor market outcomes."The post Analysis: Health-Related Workplace Absences Decline Following Medical Cannabis Legalization appeared first on NORML.
"Cannabis-based medicines may offer an alternative to traditional treatments," researchers concluded.The post Scientific Review: Cannabis-Based Interventions Significantly Reduce Tic Severity in Patients With Tourette Syndrome appeared first on NORML.
Market demand for legal cannabis products has remained steady while wholesale prices have fallen.The post Analysis: State-Legal Cannabis Sales Held Firm in 2025, Exceeding $29 Billion appeared first on NORML.
"Cannabis use for sleep is rising in popularity in the United States," the study's authors concluded.The post Survey: Nearly Ten Percent of US Adults Say They Use Cannabis To Promote Sleep appeared first on NORML.